Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race

被引：0
作者：
Soliman, K. [1 ]
Salas, A. Posadas [1 ]
Taber, D. [1 ]
机构：
[1] MUSC, Transplant, Charleston, SC USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C164
引用
收藏
页码：669 / 669
页数：1
相关论文
共 50 条
  • [31] Effect of Corticosteroid Withdrawal on Tacrolimus and Mycophenolate Mofetil Exposure in a Randomized Multicenter Study
    Shihab, F. S.
    Lee, S. T.
    Smith, L. D.
    Woodle, E. S.
    Pirsch, J. D.
    Gaber, A. O.
    Henning, A. K.
    Reisfield, R.
    Fitzsimmons, W.
    Holman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (02) : 474 - 484
  • [32] Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients
    Ciancio, G
    Burke, GW
    Suzart, K
    Roth, D
    Kupin, W
    Rosen, A
    Gomez, C
    Mattiazzi, A
    Esquenazi, V
    Miller, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1617 - 1618
  • [33] Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids
    Cristelli, M. P.
    Tedesco-Silva, H.
    Medina-Pestana, J. O.
    Franco, M. F.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (04) : 369 - 378
  • [34] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086
  • [35] Tacrolimus or cyclosporine:: Which is the better partner for mycophenolate-mofetil in heart transplant recipients?
    Meiser, BM
    Groetzner, J
    Kaczmarek, I
    Landwehr, P
    Müller, M
    Jung, S
    Überfuhr, P
    Fraunberger, P
    Stempfle, HU
    Weis, M
    Reichart, B
    TRANSPLANTATION, 2004, 78 (04) : 591 - 598
  • [36] Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients
    Teebken, OE
    Strüber, M
    Harringer, W
    Pichlmaier, MA
    Haverich, A
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (04) : 1265 - 1268
  • [37] Sirolimus or mycophenolate mofetiel (MMF): Which is the better partner for tacrolimus in heart transplant recipients?
    Groetzner, J.
    Wittwer, T.
    Strauch, J.
    Madershahian, N.
    Nagib, R.
    Franke, U.
    Wahlers, Th.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02) : S167 - S167
  • [38] Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients
    Miller, J
    Mendez, R
    Pirsch, JD
    Jensik, SC
    TRANSPLANTATION, 2000, 69 (05) : 875 - 880
  • [39] Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients:: Preliminary report in Chile
    Mueller, H.
    Solari, S.
    Zuniga, C.
    Pedreros, C.
    Troncoso, J.
    Morente, C.
    Ovalle, R.
    Acosta, P.
    Chavez, T.
    Albornoz, E.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (03) : 705 - 707
  • [40] Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: The CASL experience with mycophenolate mofetil and tacrolimus
    Chatur, N
    Ramji, A
    Bain, V
    Ma, M
    Marotta, P
    Ghent, C
    Lilly, L
    Heathcote, J
    Deschenes, M
    Steinbrecher, U
    Yoshida, E
    GASTROENTEROLOGY, 2004, 126 (04) : A734 - A735
12345